Rezolute Inc. (RZLT)
NASDAQ: RZLT
· Real-Time Price · USD
9.00
0.58 (6.89%)
At close: Oct 15, 2025, 3:59 PM
9.00
0.00%
After-hours: Oct 15, 2025, 04:10 PM EDT
6.89% (1D)
| Bid | 8.95 |
| Market Cap | 817.45M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -74.41M |
| EPS (ttm) | -0.98 |
| PE Ratio (ttm) | -9.18 |
| Forward PE | -7.76 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 9.05 |
| Volume | 1,340,126 |
| Avg. Volume (20D) | 1,124,415 |
| Open | 8.50 |
| Previous Close | 8.42 |
| Day's Range | 8.47 - 9.04 |
| 52-Week Range | 2.21 - 9.72 |
| Beta | 0.05 |
| Ex-Dividend Date | n/a |
About RZLT
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol RZLT
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for RZLT stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts5 months ago
+27.65%
Rezolute shares are trading higher after the compa...
Unlock content with
Pro Subscription
4 weeks ago · seekingalpha.com
Rezolute: FDA Pivotal Trial Alignment Change Further Bolsters ErsodetugRezolute is advancing ersodetug in two phase 3 trials for hyperinsulinism: sunRIZE for congenital HI and upLIFT for tumor HI, respectively. RZLT secured FDA alignment for the upLIFT pivotal trial, all...
